AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ...

Across these diverse applications, where the product could be a bioactive protein, virus or another large molecule, the process of mammalian “cell factory” development still relies upon the use of a ...

As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the ...

Astraveus SAS ("Astraveus" or the "Company"), the benchtop cell factory company, today announces that it has entered into a strategic partnership with The Netherlands Center for the Clinical ...

Astraveus' technology possesses the ability to simultaneously decrease manufacturing costs while increasing process ...

South Korea's LG group remains committed to Indonesia and will increase its investment in a battery cell factory by $1.7 ...

Additionally, NecstGen will produce Lentiviral vectors for Astraveus’ internal research and development needs. Astraveus recently demonstrated the potential of its revolutionary Lakhesys Benchtop Cell ...

NecstGen will produce Lentiviral vectors for Astraveus' internal research and development needs. Astraveus recently demonstrated the potential of its revolutionary Lakhesys Benchtop Cell Factory ...